Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Differential effects of endothelin-1 on normal and postischemic reperfused myocardium.

Zaugg CE, Zhu P, Simper D, Lüscher TF, Allegrini PR, Buser PT.

J Cardiovasc Pharmacol. 1993;22 Suppl 8:S367-70.

PMID:
7509989
2.

Endothelin-1-induced release of thromboxane A2 increases the vasoconstrictor effect of endothelin-1 in postischemic reperfused rat hearts.

Zaugg CE, Hornstein PS, Zhu P, Simper D, Lüscher TF, Allegrini PR, Buser PT.

Circulation. 1996 Aug 15;94(4):742-7.

3.

Endothelin-1 increases susceptibility of isolated rat hearts to ischemia/reperfusion injury by reducing coronary flow.

de Groot MC, Illing B, Horn M, Urban B, Haase A, Schnackerz K, Neubauer S.

J Mol Cell Cardiol. 1998 Dec;30(12):2657-68.

PMID:
9990537
4.

Effects of nisoldipine upon vasoconstrictor responses and binding of endothelin-1 in ischemic and reperfused rat hearts.

Watts JA, Chapat S, Johnson DE, Janis RA.

J Cardiovasc Pharmacol. 1992 Jun;19(6):929-36.

PMID:
1376815
5.
6.

Combined blockade of endothelin-1 and thromboxane A(2) receptors against postischaemic contractile dysfunction in rat hearts.

Hornstein PS, Zaugg CE, Zhu P, Allegrini PR, Buser PT.

Br J Pharmacol. 2001 Jan;132(1):234-40.

7.

Coronary vascular ATP-sensitive potassium channels are activated to a greater extent in spontaneously hypertensive rats than in Wistar-Kyoto rats.

Numaguchi K, Egashira K, Sakata M, Shimokawa H, Takeshita A.

J Hypertens. 1996 Feb;14(2):183-9.

PMID:
8728295
8.

Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.

Docherty JC, Gunter HE, Kuzio B, Shoemaker L, Yang L, Deslauriers R.

J Mol Cell Cardiol. 1997 Jun;29(6):1665-73.

PMID:
9220352
9.
11.

Effects of an endothelin receptor antagonist TAK-044 on myocardial energy metabolism in ischemia/reperfused rat hearts.

Iimuro M, Kaneko M, Matsumoto Y, Fujise Y, Watanabe T, Hayashi H.

J Cardiovasc Pharmacol. 2000 Mar;35(3):403-9.

PMID:
10710125
13.
14.
15.
16.

Differences in the effects of Na+-H+ exchange inhibitors on cardiac function and apoptosis in guinea-pig ischemia-reperfused hearts.

Hotta Y, Nishimaki H, Takeo T, Itoh G, Yajima M, Otsuka-Murakami H, Ishikawa N, Kawai N, Huang L, Yamada K, Yamamoto S, Matsui K, Ohashi N.

Eur J Pharmacol. 2004 Oct 25;503(1-3):109-22.

PMID:
15496305
17.

Effects of intracoronary administration of endothelin in anesthetized dogs: comparison with Bay k 8644 and U 46619.

Hom GJ, Touhey B, Rubanyi GM.

J Cardiovasc Pharmacol. 1992 Feb;19(2):194-200.

PMID:
1376788
18.

Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.

Valentin JP, Bessac AM, Maffre M, John GW.

Eur J Pharmacol. 1996 Dec 19;317(2-3):335-42.

PMID:
8997619
19.

Aspartate/glutamate-enriched blood does not improve myocardial energy metabolism during ischemia-reperfusion: a 31P magnetic resonance spectroscopic study in isolated pig hearts.

Ghomeshi HR, Tian G, Ye J, Sun J, Hoffenberg EF, Salerno TA, Deslauriers R.

J Thorac Cardiovasc Surg. 1997 Jun;113(6):1068-77; discussion 1077-80.

20.

Cardiac-derived thromboxane A2. An initiating mediator of reperfusion injury?

Byrne JG, Appleyard RF, Sun SC, Couper GS, Sloane JA, Laurence RG, Cohn LH.

J Thorac Cardiovasc Surg. 1993 Apr;105(4):689-93.

PMID:
8469003

Supplemental Content

Support Center